Title:
【発明の名称】FVIIa媒介性細胞内シグナル伝達経路に関連する反対条件の処理のためのFVIIa又はFVIIaiの使用
Document Type and Number:
Japanese Patent JP2001510168
Kind Code:
A
Abstract:
The present invention provides methods for identifying candidate drugs that modulate factor VIIa-mediated intracellular signaling by measuring the effects of such drugs on the activation of the mitogen-activated protein kinase (MAP kinase) signaling pathway.
Inventors:
Conx Baku, Lars
Bergenhem, Niels
Petersen, Lars Christian
Tastorup, me
Foster don
Bergenhem, Niels
Petersen, Lars Christian
Tastorup, me
Foster don
Application Number:
JP2000502794A
Publication Date:
July 31, 2001
Filing Date:
June 26, 1998
Export Citation:
Assignee:
Novo Nordisk Actiesel Scab
International Classes:
G01N33/50; A61K31/415; A61K31/4192; A61K31/4375; A61K31/4427; A61K31/4439; A61K31/498; A61K38/46; A61K38/48; A61K45/00; A61P9/00; A61P9/10; A61P35/00; A61P43/00; C07D231/12; C07D241/44; C07D249/04; C07D401/04; C07D471/04; C12Q1/06; G01N33/15; G01N33/86; (IPC1-7): A61K45/00; A61K31/415; A61K31/4192; A61K31/4375; A61K31/4439; A61K31/498; A61K38/46; A61P9/00; A61P9/10; A61P35/00; A61P43/00; C07D471/04; C12Q1/06; G01N33/15; G01N33/50
Attorney, Agent or Firm:
Takashi Ishida (4 others)